跳至主要内容
临床试验/CTRI/2019/05/019103
CTRI/2019/05/019103招募中未知

A randomised controlled trial to compare the efficacy of Apremilast and Doxycycline in patients of moderate hidradenitis suppurativa.

Post Graduate institute of medical education and research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients diagnosed as HS based on the San Francisco modification of Dessau criteria and severity defined as moderate (stage II) by Hurley staging and HS-PGA score more than 3.
  • 2.Age > 18 years.
  • 3.Patients who can give valid consent.
  • 4.Willing for monthly follow-up visits for at least 3 months.

排除标准

  • 1.Pregnant and lactating mothers
  • 2.Severe hepatic/renal dysfunction
  • 3.Patients with HIV, Hepatitis B and Hepatitis C
  • 4.Inability to come for monthly follow up visits for 3 months
  • 5.Those who cannot provide consent for the study
  • 6.Known case of psychiatric disease

研究者

发起方
Post Graduate institute of medical education and research

相似试验